240 related articles for article (PubMed ID: 10658344)
1. [Molecular biology and serologic analysis in an epidemic of viral hepatitis B in vaccinated patients on hemodialysis].
Nĕmecek V; Reinis M; Konopácová A; Summerová M; König J; Kubánek J
Epidemiol Mikrobiol Imunol; 1999 Nov; 48(4):160-6. PubMed ID: 10658344
[TBL] [Abstract][Full Text] [Related]
2. [Investigation of hemodialysis patients in terms of the presence of occult hepatitis B].
Altindiş M; Uslan I; Cetinkaya Z; Yüksel S; Ciftçi IH; Demirtürk N; Ozdemir M; Arslan F; Aktepe OC
Mikrobiyol Bul; 2007 Apr; 41(2):227-33. PubMed ID: 17682709
[TBL] [Abstract][Full Text] [Related]
3. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
[TBL] [Abstract][Full Text] [Related]
4. Low levels of awareness, vaccine coverage, and the need for boosters among health care workers in tertiary care hospitals in India.
Sukriti ; Pati NT; Sethi A; Agrawal K; Agrawal K; Kumar GT; Kumar M; Kaanan AT; Sarin SK
J Gastroenterol Hepatol; 2008 Nov; 23(11):1710-5. PubMed ID: 18761556
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
Halota W; Muszyńska M; Pawłowska M
Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201
[TBL] [Abstract][Full Text] [Related]
6. Acute hepatitis B virus infection by genotype F despite successful vaccination in an immune-competent German patient.
Tacke F; Amini-Bavil-Olyaee S; Heim A; Luedde T; Manns MP; Trautwein C
J Clin Virol; 2007 Apr; 38(4):353-7. PubMed ID: 17324621
[TBL] [Abstract][Full Text] [Related]
7. The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
Kara IH; Yilmaz ME; Suner A; Kadiroglu AK; Isikoglu B
Vaccine; 2004 Sep; 22(29-30):3963-7. PubMed ID: 15364445
[TBL] [Abstract][Full Text] [Related]
8. A serological and molecular survey of hepatitis B in children 15 years after inception of the national hepatitis B vaccination program in eastern China.
Dong Y; Liu SL; Zhai XJ; Zhu FC; Pan H; Yu JX; Chen YZ; Xie YR; Zhang XY; Zhang HM; Li LJ; Wang H; Ruan B
J Med Virol; 2009 Sep; 81(9):1517-24. PubMed ID: 19626618
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of prophylactic vaccination against Hepatitis B Virus infection viruses in hemodialyzed patients].
Urbanowicz W
Przegl Epidemiol; 2000; 54(3-4):343-50. PubMed ID: 11349597
[TBL] [Abstract][Full Text] [Related]
10. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
Kim KH; Ahn SH; Chung HY; Paik YH; Lee KS; Kim YS; Chon CY; Moon YM; Han KH
J Gastroenterol Hepatol; 2004 Aug; 19(8):847-53. PubMed ID: 15242485
[TBL] [Abstract][Full Text] [Related]
12. The status of immunity against the hepatitis B virus among vaccinated hemodialysis patients: a single center report from Iran.
Khamene ZR; Sepehrvand N
Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):547-50. PubMed ID: 17951941
[TBL] [Abstract][Full Text] [Related]
13. [The response to the hepatitis B virus vaccine in patients undergoing hemodialysis and peritoneal dialysis--personal experience].
Majdan M; Polz M; Ksiazek A; Janicka L; Kozioł M; Swatowski A; Orłowska G
Przegl Lek; 1995; 52(6):307-10. PubMed ID: 7568985
[TBL] [Abstract][Full Text] [Related]
14. [Significance of isolated anti-HBs antibodies in subjects not vaccinated against hepatitis B viruses].
Driss F; Zarski JP; Courouce AM; Eme D; Brechot C; Berthelot P; Tron F; Nalpas B
Gastroenterol Clin Biol; 1991; 15(6-7):477-80. PubMed ID: 1916124
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of serologic marker screening in identifying hepatitis B virus infection in organ, tissue, and cell donors.
Challine D; Chevaliez S; Pawlotsky JM
Gastroenterology; 2008 Oct; 135(4):1185-91. PubMed ID: 18694749
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus transmission pattern and vaccination efficiency in Uzbekistan.
Avazova D; Kurbanov F; Tanaka Y; Sugiyama M; Radchenko I; Ruziev D; Musabaev E; Mizokami M
J Med Virol; 2008 Feb; 80(2):217-24. PubMed ID: 18098129
[TBL] [Abstract][Full Text] [Related]
18. Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals.
Da Villa G; Romanò L; Sepe A; Iorio R; Paribello N; Zappa A; Zanetti AR
Vaccine; 2007 Apr; 25(16):3133-6. PubMed ID: 17280750
[TBL] [Abstract][Full Text] [Related]
19. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan.
Mu SC; Lin YM; Jow GM; Chen BF
J Hepatol; 2009 Feb; 50(2):264-72. PubMed ID: 19070923
[TBL] [Abstract][Full Text] [Related]
20. Screening for hepatitis A and B antibodies in patients with chronic liver disease.
Lau DT; Hewlett AT
Am J Med; 2005 Oct; 118 Suppl 10A():28S-33S. PubMed ID: 16271538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
